新癀片对比清开灵胶囊治疗带状疱疹的成本-效果分析

The Cost-effectiveness Analysis of Xinhuangtablet Compared with Qingkailing Capsules in the Treatment of Herpes Zoster

目的:比较新癀片与清开灵胶囊治疗带状疱疹的经济性,为临床用药提供参考。方法:检索中国知网(CNKI)、维普中文科技期刊全文数据库(CQVIP)等电子资料源数据库,查寻国内关于新癀片及清开灵胶囊治疗带状疱疹的临床疗效文献,并通过构建决策树模型对新癀片及清开灵胶囊治疗方案进行成本效果分析。结果:新癀片方案治疗带状疱疹的总成本为55.09元,清开灵胶囊方案的总成本为61.07元;新癀片方案的有效率为97.6%,清开灵胶囊方案的有效率为83.3%。与清开灵胶囊相比,增量成本效果比(ICER)显示新癀片治疗带状疱疹为绝对优势方案。结论:与清开灵胶囊相比,新癀片在治疗带状疱疹方面更具成本效果优势。

Objective： To evaluate the cost effectiveness of Xinhuangtablet and Qingkailing capsules in the treatment of herpes zoster,and to provide clinicians with some advice. Methods： A systematic of literatures was conducted via CNKI,CQVIP,etc,to identify clinical literature on the treatment of herpes zoster with Xinhuangtablet and Qingkailing Capsules,and through construction of the decision tree model,cost-effectiveness analysis was used to compare the cost effect value of the two groups. Results： The total cost for Xinhuangtablet group and Qingkailing capsules group was $ 55. 09 and $ 61. 07. The effective rate of two groups was 97. 6% and 83. 3%. ICER showed the Xinhuangtablet group was absolute advantage scheme. Conclusion： Compared with Qingkailing capsules,Xinhuangtablet has more cost-effectiveness advantages in the treatment of herpes zoster.